Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
Johnson and Johnson
McKinsey
Accenture
Baxter
Covington
Federal Trade Commission
Citi

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021850

« Back to Dashboard

NDA 021850 describes ZEGERID, which is a drug marketed by Santarus Inc, Santarus, and Bayer Healthcare Llc, and is included in five NDAs. It is available from four suppliers. Additional details are available on the ZEGERID profile page.

The generic ingredient in ZEGERID is magnesium hydroxide; omeprazole; sodium bicarbonate. There are one hundred and thirty-eight drug master file entries for this compound. Additional details are available on the magnesium hydroxide; omeprazole; sodium bicarbonate profile page.
Summary for 021850
Tradename:ZEGERID
Applicant:Santarus
Ingredient:magnesium hydroxide; omeprazole; sodium bicarbonate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength700MG;20MG;600MG
Approval Date:Mar 24, 2006TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, CHEWABLE;ORALStrength700MG;40MG;600MG
Approval Date:Mar 24, 2006TE:RLD:No

Expired US Patents for NDA 021850

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Santarus ZEGERID magnesium hydroxide; omeprazole; sodium bicarbonate TABLET, CHEWABLE;ORAL 021850-002 Mar 24, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Santarus ZEGERID magnesium hydroxide; omeprazole; sodium bicarbonate TABLET, CHEWABLE;ORAL 021850-001 Mar 24, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Santarus ZEGERID magnesium hydroxide; omeprazole; sodium bicarbonate TABLET, CHEWABLE;ORAL 021850-001 Mar 24, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Santarus ZEGERID magnesium hydroxide; omeprazole; sodium bicarbonate TABLET, CHEWABLE;ORAL 021850-002 Mar 24, 2006 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Cerilliant
Dow
Queensland Health
Healthtrust
Julphar
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.